Country: Ирска
Језик: Енглески
Извор: HPRA (Health Products Regulatory Authority)
PARAMYXOVIRUS TYPE 3 INACTIVATED, NEWCASTLE DISEASE VIRUS, ULSTER 2C STRAIN INACTIVATED, TURKEY RHINOTRACHEITIS VIRUS
Merial Animal Health Limited
QI01CA02
PARAMYXOVIRUS TYPE 3 INACTIVATED, NEWCASTLE DISEASE VIRUS, ULSTER 2C STRAIN INACTIVATED, TURKEY RHINOTRACHEITIS VIRUS
Unknown
Emulsion for Injection
POM
Fowl - Turkey
Turkey paramyxovirus vaccine + Turkey rhinotracheitis virus vaccine
Immunological - Inactivated vaccine
Authorised
2006-12-21
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT TUR-3 emulsion for injection for turkeys. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Emulsion for injection. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Turkeys intended for breeding. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For active immunisation of future breeder turkeys: - as booster vaccination after priming with live vaccines against Newcastle Disease and Turkey Rhinotracheitis to reduce mortality and clinical signs of Newcastle Disease and to induce a specific seroconversion against Newcastle Disease and Turkey Rhinotracheitis in vaccinated birds throughout the laying period - as vaccination against paramyxovirus type 3 to reduce the decrease in egg production, as demonstrated by challenge at peak of lay, and to induce a specific seroconversion against paramyxovirus type 3 throughout the laying period. Onset of immunity: 4 weeks after the first dose of the vaccination schedule. The second dose is required to achieve protection for the specified duration of immunity. Duration of immunity: one laying period (demonstrated by serology). Each dose of vaccine contains: ACTIVE SUBSTANCES: Paramyxovirus 3, inactivated strain PMV3, at least 40 HI.U Newcastle Disease virus, inactivated strain Ulster 2C, at least 50 PD50 Turkey rhinotracheitis virus, inactivated, strain VCO3, at least 9 ELISA.U ADJUVANT: Paraffin oil 170 to186 mg Ester of fatty acids and polyols 6 to 15 mg For a full list of excipients, see section 6.1. 1 HIU: q.s. to obtain a mean haemagglutination inhibiting antibody titre of 1 in the vaccinated animal PD50: Minimum protective dose in accordance with Ph.Eur. 870. 1 ELISA U.: q.s. to obtain a positive serum by ELISA in the vaccinated bird IRISH MEDICINES BOAR Прочитајте комплетан документ